Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanouil Fokas

Showing results (41-50 of 158) with videos related to

Pageof 16
Sort By:
Biochimica Et Biophysica Acta|December 10, 2014
Pancreatic ductal adenocarcinoma: From genetics to biology to radiobiology to oncoimmunology and all the way back to the clinicEmmanouil Fokas, Eric O'Neill, Alex Gordon-Weeks, et al.
JAMA Network Open|October 30, 2023
Overall Survival After Treatment Failure Among Patients With Rectal CancerMarkus Diefenhardt, Daniel Martin, Maximilian Fleischmann, et al.
BMC Neurology|February 18, 2021
Single-shot bevacizumab for cerebral radiation injuryMartin Voss, Katharina J Wenger, Emmanouil Fokas, et al.
Acta Oncologica (Stockholm, Sweden)|May 25, 2026
Dose-de-escalated focal radiotherapy for primary cutaneous T-cell lymphoma: a lesion-based retrospective cohort studyPhilipp Linde, Kathrin Wagner, Johannes Rosenbrock, et al.
Cancer Treatment Reviews|April 16, 2013
Targeting ATR in DNA damage response and cancer therapeuticsEmmanouil Fokas, Remko Prevo, Ester M Hammond, et al.
Nature Reviews. Clinical Oncology|May 13, 2025
Emerging advances and future opportunities in the molecular and therapeutic landscape of anal cancerFranz Rödel, Maximilian Fleischmann, Markus Diefenhardt, et al.
Cells|May 21, 2020
Fractionation-Dependent Radiosensitization by Molecular Targeting of Nek1Isabel Freund, Stephanie Hehlgans, Daniel Martin, et al.
International Journal of Radiation Oncology, Biology, Physics|May 14, 2013
Nuclear NF-κB expression correlates with outcome among patients with head and neck squamous cell carcinoma treated with primary chemoradiation therapyPanagiotis Balermpas, Yvonne Michel, Jens Wagenblast, et al.
Cancers|April 17, 2019
Targeted Therapies and Immune-Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma: Where Do We Stand Today and Where to Go?Jens von der Grün, Franz Rödel, Christian Brandts, et al.
Oncoimmunology|April 14, 2017
Human papilloma virus load and PD-1/PD-L1, CD8<sup>+</sup> and FOXP3 in anal cancer patients treated with chemoradiotherapy: Rationale for immunotherapyPanagiotis Balermpas, Daniel Martin, Ulrike Wieland, et al.
Pageof 16

Showing results (41-50 of 158) with videos related to

Sort By:
Pageof 16
Biochimica Et Biophysica Acta|December 10, 2014
Pancreatic ductal adenocarcinoma: From genetics to biology to radiobiology to oncoimmunology and all the way back to the clinicEmmanouil Fokas, Eric O'Neill, Alex Gordon-Weeks, et al.
JAMA Network Open|October 30, 2023
Overall Survival After Treatment Failure Among Patients With Rectal CancerMarkus Diefenhardt, Daniel Martin, Maximilian Fleischmann, et al.
BMC Neurology|February 18, 2021
Single-shot bevacizumab for cerebral radiation injuryMartin Voss, Katharina J Wenger, Emmanouil Fokas, et al.
Acta Oncologica (Stockholm, Sweden)|May 25, 2026
Dose-de-escalated focal radiotherapy for primary cutaneous T-cell lymphoma: a lesion-based retrospective cohort studyPhilipp Linde, Kathrin Wagner, Johannes Rosenbrock, et al.
Cancer Treatment Reviews|April 16, 2013
Targeting ATR in DNA damage response and cancer therapeuticsEmmanouil Fokas, Remko Prevo, Ester M Hammond, et al.
Nature Reviews. Clinical Oncology|May 13, 2025
Emerging advances and future opportunities in the molecular and therapeutic landscape of anal cancerFranz Rödel, Maximilian Fleischmann, Markus Diefenhardt, et al.
Cells|May 21, 2020
Fractionation-Dependent Radiosensitization by Molecular Targeting of Nek1Isabel Freund, Stephanie Hehlgans, Daniel Martin, et al.
International Journal of Radiation Oncology, Biology, Physics|May 14, 2013
Nuclear NF-κB expression correlates with outcome among patients with head and neck squamous cell carcinoma treated with primary chemoradiation therapyPanagiotis Balermpas, Yvonne Michel, Jens Wagenblast, et al.
Cancers|April 17, 2019
Targeted Therapies and Immune-Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma: Where Do We Stand Today and Where to Go?Jens von der Grün, Franz Rödel, Christian Brandts, et al.
Oncoimmunology|April 14, 2017
Human papilloma virus load and PD-1/PD-L1, CD8<sup>+</sup> and FOXP3 in anal cancer patients treated with chemoradiotherapy: Rationale for immunotherapyPanagiotis Balermpas, Daniel Martin, Ulrike Wieland, et al.
Pageof 16